This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Waller, J. Articles by Wardle, J. Search for Related Content PubMed PubMed Citation Articles by Waller, J. Articles by Wardle, J.

Mothers' Attitudes towards Preventing Cervical Cancer through Human Papillomavirus Vaccination: A Qualitative Study

Cancer Research UK Health Behaviour Unit, Department of Epidemiology and Public Health, University College London, London, United Kingdom

Requests for reprints: Jo Waller, Cancer Research UK Health Behaviour Unit, Department of Epidemiology and Public Health, University College London, 2-16 Torrington Place, London WC1E 6BT, United Kingdom. Phone: 44-20-7679-5966; Fax: 44-20-7813-2848. E-mail: j.waller{at}ucl.ac.uk

Prophylactic vaccines against human papillomavirus (HPV) types causing cervical cancer will soon be available. Success of the vaccine relies on parents' willingness to vaccinate their prepubescent daughters. We explored mothers' attitudes towards vaccination. Twenty-four mothers of girls ages 8 to 14 years took part in four focus groups. Discussions covered attitudes to vaccination in general, cancer vaccines, vaccines for sexually transmitted infections (STI), and the HPV vaccine. Discussions were recorded, transcribed, and analyzed thematically. Mothers were broadly provaccination. Some were excited about a cancer vaccine, although there were fears that it might lead to unhealthy behaviors (e.g., smoking). STI vaccines got a mixed reception. Enthusiasm was moderated by concerns about an increase in risky sexual behavior. When provided with information about the HPV vaccine, women were in favor of protecting their daughters from cervical cancer, abnormal Papanicolaou results and, potentially, from cervical screening. Some worried about an increase in promiscuity and risk of other STIs. There was disagreement about the age at which girls should be vaccinated. Although some women thought this question should be medically driven, others were concerned about discussing the vaccine with young girls and preferred to wait until they were older. In conclusion, mothers were broadly in favor of HPV vaccination but had reservations, particularly about vaccinating girls as young as 10. Larger-scale quantitative work is needed to assess acceptability at the population level. If the vaccine is introduced, information provision is likely to be key to ensuring parents understand the rationale for vaccinating at a young age. (Cancer Epidemiol Biomarkers Prev 2006;15(7):1257–61)

This article has been cited by other articles:

				L. A V Marlow, J. Waller, and J. Wardle Sociodemographic predictors of HPV testing and vaccination acceptability: results from a population-representative sample of British women J Med Screen, June 1, 2008; 15(2): 91 - 96. [Abstract] [Full Text] [PDF]

				J. Waller and J. Wardle HPV vaccination in the UK BMJ, May 10, 2008; 336(7652): 1028 - 1029. [Full Text] [PDF]

				D S Hughes, N Powell, and A N Fiander Will vaccination against human papillomavirus prevent eye disease? A review of the evidence Br. J. Ophthalmol., April 1, 2008; 92(4): 460 - 465. [Abstract] [Full Text] [PDF]

				A. L. Sussman, D. Helitzer, M. Sanders, B. Urquieta, M. Salvador, and K. Ndiaye HPV and Cervical Cancer Prevention Counseling With Younger Adolescents: Implications for Primary Care Ann. Fam. Med, July 1, 2007; 5(4): 298 - 304. [Abstract] [Full Text] [PDF]